H. N. Dogan

558 total citations
11 papers, 505 citations indexed

About

H. N. Dogan is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, H. N. Dogan has authored 11 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 2 papers in Molecular Biology and 1 paper in Cellular and Molecular Neuroscience. Recurrent topics in H. N. Dogan's work include Synthesis and Characterization of Heterocyclic Compounds (8 papers), Synthesis and biological activity (8 papers) and Click Chemistry and Applications (4 papers). H. N. Dogan is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (8 papers), Synthesis and biological activity (8 papers) and Click Chemistry and Applications (4 papers). H. N. Dogan collaborates with scholars based in Türkiye. H. N. Dogan's co-authors include Sevım Rollas, Arzu Duran, Dumrul Gülen, Meral Keyer Uysal, Göksel Şener, Habibe Erdeniz, Nehir Gülerman, Adile Çevikbaş and Meral Keyer‐Uysal and has published in prestigious journals such as Bioorganic & Medicinal Chemistry, Drug Metabolism Letters and Il Farmaco.

In The Last Decade

H. N. Dogan

10 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. N. Dogan Türkiye 7 457 103 28 26 26 11 505
Nehir Gülerman Türkiye 5 346 0.8× 79 0.8× 44 1.6× 19 0.7× 49 1.9× 7 387
N. Tugba Durlu Türkiye 5 459 1.0× 67 0.7× 21 0.8× 20 0.8× 26 1.0× 8 565
Charalabos Camoutsis Greece 5 459 1.0× 160 1.6× 16 0.6× 22 0.8× 16 0.6× 9 522
J. Thanusu India 15 542 1.2× 163 1.6× 53 1.9× 25 1.0× 33 1.3× 49 623
Habibe Erdeniz Türkiye 7 528 1.2× 96 0.9× 47 1.7× 21 0.8× 73 2.8× 11 585
Iana Vazzana Italy 10 288 0.6× 84 0.8× 14 0.5× 19 0.7× 32 1.2× 18 361
T. Arulmoli India 9 379 0.8× 100 1.0× 30 1.1× 10 0.4× 46 1.8× 13 466
Khursheed Ansari India 8 391 0.9× 106 1.0× 25 0.9× 10 0.4× 34 1.3× 12 468
M. A. EL‐GENDY Egypt 10 325 0.7× 109 1.1× 9 0.3× 20 0.8× 21 0.8× 20 445
Keiko Ofuji Japan 5 484 1.1× 152 1.5× 24 0.9× 16 0.6× 37 1.4× 6 579

Countries citing papers authored by H. N. Dogan

Since Specialization
Citations

This map shows the geographic impact of H. N. Dogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. N. Dogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. N. Dogan more than expected).

Fields of papers citing papers by H. N. Dogan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. N. Dogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. N. Dogan. The network helps show where H. N. Dogan may publish in the future.

Co-authorship network of co-authors of H. N. Dogan

This figure shows the co-authorship network connecting the top 25 collaborators of H. N. Dogan. A scholar is included among the top collaborators of H. N. Dogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. N. Dogan. H. N. Dogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Duran, Arzu, et al.. (2014). Simultaneous Quantitative Determinations of Fluticasone Propionate and Salmeterol Xinafote in Diskus Inhalers. Drug Metabolism Letters. 8(1). 31–35. 5 indexed citations
3.
Dogan, H. N., Arzu Duran, & Sevım Rollas. (2005). Synthesis and preliminary anticancer activity of new 1 H -4,5-dihydro-3-(3-hydroxy-2-naphthyl)-4-substituted-1,2,4-triazoline-5-thiones. Part II. Dspace Repository (Marmara Üniversitesi). 44(11). 2301–2307. 14 indexed citations
4.
Rollas, Sevım, H. N. Dogan, Meral Keyer‐Uysal, & Göksel Şener. (2003). 2-(3-Acetyloxy-2-naphthyl)-4-acetyl-5-phenyl-1,3,4-oxadiazoline suppresses pentylenetetrazol-induced convulsive and oxidative activity on mice. Dspace Repository (Marmara Üniversitesi). 1 indexed citations
5.
Dogan, H. N., Arzu Duran, Sevım Rollas, et al.. (2002). Synthesis of new 2,5-Disubstituted-1,3,4-thiadiazoles and preliminary evaluation of anticonvulsant and antimicrobial activities. Bioorganic & Medicinal Chemistry. 10(9). 2893–2898. 229 indexed citations
6.
Duran, Arzu, H. N. Dogan, & Sevım Rollas. (2002). Synthesis and preliminary anticancer activity of new 1,4-dihydro-3-(3-hydroxy-2-naphthyl)-4-substituted-5H-1,2,4-triazoline-5-thiones. Il Farmaco. 57(7). 559–564. 84 indexed citations
7.
8.
Dogan, H. N., et al.. (1999). SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF 1-(3-HYDROXY-2-NAPHTHOYL)-4-SUBSTITUTED THIOSEMICARBAZIDES. Drug metabolism and drug interactions. 15(2-3). 187–196. 10 indexed citations
9.
Dogan, H. N., Sevım Rollas, & Habibe Erdeniz. (1998). Synthesis, structure elucidation and antimicrobial activity of some 3-hydroxy-2-naphthoic acid hydrazide derivatives. Il Farmaco. 53(7). 462–467. 63 indexed citations
11.
Dogan, H. N.. (1996). 吸光度比法による製剤中のアセトアミノフェン,ジピロン,カフェインの同時分析. Pharmazie. 51(10). 773–774. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026